Launches and acquisitions driving OTC growth

Launches and acquisitions driving OTC growth


22 October 2015 - Deborah Wilkes


This 'OTC Results Comparisons' Briefing provides an easy way to compare the recent financial results and trends of leading OTC businesses worldwide.

The OTCToolbox Briefing covers financial results reported by selected branded OTC players in the first half of 2015. Key trends are identified in a feature article, while selected OTC businesses are covered in more detail in individual company results profiles.

OTC businesses featured in the Briefing are Bayer Consumer Care, Boehringer Ingelheim Consumer Health Care, GlaxoSmithKline Consumer Healthcare, Johnson & Johnson OTC, Meda Cx/OTC, Merck Consumer Health, Perrigo Branded Consumer Healthcare, Pfizer Consumer Healthcare, Prestige Brands, Procter & Gamble Health Care, RB Health, Sanofi Consumer Healthcare, Stada Branded Products, and Taisho Self-Medication.

Acquisitions and product launches, including switches, were the talking point when many of the leading OTC players released their financial results at the end of the first half of 2015. Manufacturing problems, emerging markets, the cough/cold season and the impact of currency translations also featured prominently.

The Briefing is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox.

It is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Briefing. The Briefing is available free to people who have a current paid-for Annual Subscription to the OTCToolbox website.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Briefings

Share this page: